Clinical Trial Update: A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01) [Phase 1]

View source ↗

Summary

This update summarizes a Phase 1 study of CDX-1307 in patients with incurable breast, colorectal, pancreatic, ovarian, or bladder cancer. The trial status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Breast Cancer
• Colorectal Cancer
• Ovarian Cancer
• Pancreatic Cancer

Drugs mentioned

• CDX-1307 (hCG-B vaccine)

Snippet

Sponsor: Celldex Therapeutics | Conditions: Breast Cancer, Colorectal Cancer | Phase 1 | Status: COMPLETED